South Korea Botulinum Toxin Type A Market Size, Share & Trends Analysis Report By Application (Upper Face, Mid Face, Lower Face, Body), By Gender ( Female, Male), By Age, By End-use, And Segment Forecasts, 2024 - 2030

South Korea Botulinum Toxin Type A Market Size, Share & Trends Analysis Report By Application (Upper Face, Mid Face, Lower Face, Body), By Gender ( Female, Male), By Age, By End-use, And Segment Forecasts, 2024 - 2030


South Korea Botulinum Toxin Type A Market Growth & Trends

The South Korea botulinum toxin type A market size is anticipated to reach USD 386.9 Million by 2030 and expanding at a CAGR of 10.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising aesthetic consciousness among the South Korean population fuels the demand for the market. South Koreans place a high value on physical appearance, with a strong cultural emphasis on beauty and youthfulness. This societal trend has led to an increasing demand for non-invasive cosmetic procedures, including botulinum toxin treatments, to enhance and maintain one's appearance. For instance, the popularity of K-beauty standards and the influence of media and celebrities have heightened awareness and acceptance of aesthetic treatments. This growing focus on aesthetics is not limited to any specific age group, as both younger and older demographics are seeking treatments to address their cosmetic concerns, further driving the market for botulinum toxin products.

The growing consumer preference for health, safety, and authenticity has driven a strong focus on natural and organic products. According to the International Trade Administration article published in September 2023, despite a slight decrease in total local production and exports in 2022, South Korea remains one of the top 10 beauty markets globally. This trend presents new opportunities in the botulinum toxin type A market as consumers increasingly seek safe and natural cosmetic solutions. Additionally, the Ministry of Food & Drug Safety (MFDS) has introduced guidelines for natural and organic cosmetics, supporting the development and growth of this niche market within the botulinum toxin sector.

South Korea Botulinum Toxin Type A Market Report Highlights
  • In terms of application, the upper face segment held the largest share of 51.85% in 2023 and is anticipated to grow at fastest growth rate over the forecast period owing to increasing demand for aesthetic treatments aimed at reducing wrinkles in areas such as the forehead, glabella, and crow's feet.
  • Based on gender, the female segment held the largest share of 82.02% as women in South Korea often experience early signs of aging and skin dullness, influenced by hormonal fluctuations such as declining estrogen levels.
  • Based on age, 31 to 59 Years segment held the largest share of over 44.35% in 2023. This age group is typically more concerned with signs of aging such as wrinkles and fine lines, making botulinum toxin type A injections a popular choice for rejuvenating facial appearance.
  • Based on end use, the specialty clinics & aesthetic centers segment held the largest share of over 42.99% in 2023. These facilities provide a range of cosmetic procedures under one roof, catering to diverse patient needs. Moreover, clinics employ skilled dermatologists and aesthetic practitioners who specialize in facial rejuvenation and cosmetic enhancements.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Application
1.2.2. Gender
1.2.3. Age
1.2.4. End Use
1.2.5. Estimates and forecast timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity price analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application Segment
2.2.2. Gender Segment
2.2.3. Age Segment
2.2.4. End Use Segment
2.3. Competitive Insights
Chapter 3. South Korea Botulinum Toxin Type A Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing demand for aesthetic procedures
3.2.1.2. Advancements in technology and techniques
3.2.1.3. Rising disposable income
3.2.1.4. Increasing applications beyond cosmetic use
3.2.2. Market restraint analysis
3.2.2.1. Stringent Regulatory Policies
3.3. South Korea Botulinum Toxin Type A Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. South Korea Botulinum Toxin Type A Market: Application Estimates & Trend Analysis
4.1. South Korea Botulinum Toxin Type A Market: Application Dashboard
4.2. South Korea Botulinum Toxin Type A Market: Application Movement Analysis
4.3. South Korea Botulinum Toxin Type A Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
4.4. Upper Face
4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.4.1.1. Glabellar Wrinkles
4.4.1.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.4.1.2. Forehead Wrinkles
4.4.1.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.4.1.3. Crow’s Feet
4.4.1.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Mid Face
4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.6. Lower Face
4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.7. Body
4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. South Korea Botulinum Toxin Type A Market: Gender Estimates & Trend Analysis
5.1. South Korea Botulinum Toxin Type A Market: Gender Dashboard
5.2. South Korea Botulinum Toxin Type A Market: Gender Movement Analysis
5.3. South Korea Botulinum Toxin Type A Market Size & Forecasts and Trend Analysis, by Gender, 2018 to 2030 (USD Million)
5.4. Female
5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5. Male
5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. South Korea Botulinum Toxin Type A Market: Age Estimates & Trend Analysis
6.1. South Korea Botulinum Toxin Type A Market: Age Dashboard
6.2. South Korea Botulinum Toxin Type A Market: Age Movement Analysis
6.3. South Korea Botulinum Toxin Type A Market Size & Forecasts and Trend Analysis, by Age, 2018 to 2030 (USD Million)
6.4. Below 30 Years
6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.5. 31 to 59 Years
6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.6. Over 60 Years
6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. South Korea Botulinum Toxin Type A Market: End-use Estimates & Trend Analysis
7.1. South Korea Botulinum Toxin Type A Market: End-use Dashboard
7.2. South Korea Botulinum Toxin Type A Market: End-use Movement Analysis
7.3. South Korea Botulinum Toxin Type A Market Size & Forecasts and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
7.4. Hospitals
7.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
7.5. Specialty Clinics & Aesthetic Centers
7.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
7.6. Medspas
7.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Manufacturers
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. Hugel
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Gender benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Medytox
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Gender benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Daewoong
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Gender benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Galderma
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Gender benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Ipsen
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Gender benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Huons Global
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Gender benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Pharma Research BIO
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Gender benchmarking
8.3.10.4. Strategic initiatives
8.3.11. AbbVie
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Gender benchmarking
8.3.11.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings